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Background: Oil tea is a type of traditional tea beverage used for treating various ailments in minority population
in Guangxi, China. Our previous study showed oil tea improved glucose and lipid levels in type 2 diabetic mice. Yet,
the underling molecular mechanisms are still not understood. This study aimed at assessing the effect of oil tea on
glucose homeostasis and elucidating the molecular mechanisms underlying the oil tea-induced antidiabetic effects.
Methods: Twenty seven db/db mice were gavaged with saline, metformin and oil tea for 8 weeks with
measurement of biochemical profiles. A real-time2 (RT2) profiler polymerase chain reaction (PCR) array comprising
84 genes involved in glucose metabolism was measured and validated by quantitative PCR (qPCR). The association
between the candidate genes and type 2 diabetes were further analyzed in a case-control study in the Chinese
minority population.
Results: Oil tea treatment facilitated glucose homeostasis by decreasing fasting blood glucose and total
cholesterol, and improving glucose tolerance. Suppressing phosphoenolpyruvate carboxykinase 1 (PCK1) expression
was observed in the oil tea treatment group and the expression was significantly correlated with fasting blood
glucose levels. Target prediction and functional annotation by WEB-based GEne SeT AnaLysis Toolkit (WebGestalt)
revealed that PCK1 mainly involved in the glycolysis/gluconeogenesis pathway among the top Kyoto Encyclopedia
of Genes and Genomes (KEGG) database pathways. Both rs707555 and rs2071023 in PCK1 were significantly
associated with type 2 diabetes in the minority population of Guangxi.
Conclusion: Our findings indicated oil tea improved glucose homeostasis via down-regulation of PCK1 and PCK1
may be a genetic marker for the treatment of type 2 diabetes.
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Oil tea is a unique beverage and an important dietary
component in the minority areas of Guangxi Province,
China. Oil tea is rich in polyphenol, caffeine, 6-gingerol
and several minerals [1], and is the most popular
traditional beverage used for treating various ailments in
Guangxi [2]. Green tea and ginger, as the main ingredi-
ents of oil tea, individually have exhibited various bio-
logical activities, including anticancer effects, antioxidative
effects, and antidiabetic effects [3–5]. Previously, our
study showed oil tea treatment improved hyperglycemia,
glucose intolerance and hyperlipidemia in db/db mice [1].
While the underlying molecular mechanisms of the
beneficial effects of oil tea was unknown.
Phosphoenolpyruvate carboxykinase 1 (PCK1) is a key
gluconeogenic enzyme in the liver [6]. It is the cytosolic
form of phosphoenolpyruvate carboxykinase (PCK or
PEPCK) and catalyzes the initial step in hepatic gluco-
neogenesis. The expression of PCK1 gene is regulated by
insulin, glucocorticoids, glucagon, cyclic adenosine
monophosphate (cAMP) and diet, all of which have been
considered associated with diabetic conditions. It has
been reported that PCK1 is up-regulated in diabetic
rodent models [7], and overexpression in the transgenic
mice resulted in insulin resistance [8] and hyperglycemia
[9]. Reciprocally, silencing of PCK1 has been demon-
strated to improve glycemia control, insulin sensitivity
and dyslipidemia in db/db mice [10]. Furthermore, re-
search has indicated that induced expression of PCK1
may be a useful indicator for effect assessment in dia-
betes therapy. Indeed, studies of the effect of Rosmarinic
acid, insulin, retinoic acid and phenobarbital showed
decreased expression of PCK1 and improvement of
hyperglycemia in diabetic rats [11–13]. Moreover, PCK1
has been demonstrated to be a candidate genetic marker
for diabetes and obesity risk [14], and more recent
research implicated this locus in type 2 diabetes (T2D)
risk in Chinese [15], South Asian [16] and Finnish popu-
lations [17].
In the present study, we investigated the molecular
mechanisms of antidiabetic effect of oil tea by examining
the expression of PCK1, as well as other genes involved
in glucose metabolism in db/db mice. We also assessed
whether PCK1 is a genetic marker for T2D risk in the
minority population in Guangxi.
Methods
Preparation of oil tea
The oil tea was prepared as previously described [1, 18].
In brief, the proportions of green tea, ginger, peanut,
cooking oil and salt were 9:10:5:2:1. The manufacturing
process was as follows: firstly, soaked green tea leaf was
stir-fried and beaten with ginger, peanut and cooking oil
in a hot iron pot for 3 min, then hot water and saltadded, and the mixture boiled for 1 min and the result-
ing decoction retained. This process was repeated twice,
whereupon the mixed decoction was called oil tea. The
oil tea decoction then was concentrated by a rotary
vacuum evaporator (IKA Works, Germany) and stored
at − 80 °C until use.
Animal model and experimental design
The experimental procedures were approved by the
Animal Ethics Committee of Guangxi Center for Disease
Prevention and Control (Approval No. 20160003). Six
week-old male diabetic C57BL/KsJ-db/db (db/db) mice
were randomly divided assigned to three groups and
orally gavaged with oil tea (4 g/kg body weight (BW)/
day, n = 10), distilled water (0.02 ml/g BW/day, n = 7)
and metformin (MET, Sigma, USA, the first-line medica-
tion for treating T2D, 150mg/kg BW/day, n = 10) for 8
weeks. The oil tea contained 24.6% polyphenols and 0.3%
[6]-gingerol, as described previously [1]. Up to five mice
per cage were maintained in a temperature-controlled
(22 ± 2 °C) mouse facility on a reverse 12-h light/dark
cycle and provided water and chow-diet ad libitum.
The full nutritional composition of oil tea has been
described previously [1]. Body weight and food intake
were measured each week.
FBG detection and OGTT test
Fasting blood glucose (FBG) levels were examined every
week after the db/db mice overnight fasting. The oral
glucose tolerance test (OGTT) was performed at weeks
4 and 8 after the mice were orally gavaged with oil tea
or MET, combined with glucose solution (1 g/kg BW).
Blood glucose levels were measured in tail blood
samples collected at 0, 15, 30, 60, 90 and 120min after
glucose treatment. Blood glucose was measured using a
glucometer (OMRON Healthcare Co., Ltd., China).
Serum lipid measurement
At the end of experiment, mice were killed by cervical
dislocation, and blood samples were collected for the
measurement of biochemical profiles. Levels of serum
triglycerides (TG), total cholesterol (TC), low-density
lipoprotein (LDL) and high-density lipoprotein (HDL)
were measured using commercial kits (Shanghai
Enzyme-linked Biotechnology Co., Ltd., China). Insulin
was measured using a commercial Mouse Insulin ELISA
kit (ALPCO Diagnostics, USA).
RT2 profiler PCR array analysis
After mice were killed, the fresh livers were collected
and snap frozen in liquid nitrogen, and then stored at −
80 °C until analysis. Total RNA was isolated from the
liver samples of db/db control group and oil tea group
using Qiagen RNeasy® Mini Kit (QIAGEN, Shanghai,
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Single-strand cDNA was synthesized from 1 μg of total
RNA by reverse transcription reaction using Qiagen RT2
First Strand Kit (QIAGEN, Shanghai, China). The cDNA
was mixed with Qiagen PCR RT2 SYBR Green Master
Mix (QIAGEN, Shanghai, China).
To explore the underlying mechanisms of oil tea
induced-effects, the expression of 84 genes involved in
glucose metabolism including PCK1 were examined
using a Qiagen mouse glucose metabolism RT2 profiler
PCR array (PAMM-006Z, QIAGEN, Shanghai, China).
Relative quantification of mRNA levels was determined
by real-time quantitative PCR using a Bio-Rad CFX96
Sequence Detector instrument. The quantitative expres-
sion of gene was calculated from the cycle threshold
(CT) value of each sample in the linear part of the curve
using the relative quantification method (2−ΔΔCT) [19].
The samples were analyzed in triplicate and corrected
for the selected internal standard which had the smallest
standard deviation among the housekeeping genes. Can-
didate genes were selected from those whose expressions
differed greater than 1.25-fold or less than 0.75-fold, or
which differed significantly (p < 0.05) between the con-
trol group and oil tea treatment group.
Quantitative PCR (qPCR) analysis for the candidate genes
For those candidate genes selected from the RT2 profiler
PCR array, specific PCR primers were designed for
further quantitative real-time PCR analysis (Takara,
Dalian, China) as follows.
ALDOA: 5’- GCTCCTTAGTCCTTTCGCCT - 3’
and 5’- TCAGTGCTGGGTATGGGTG - 3’
FBP2: 5’- GATCTGTTCATGCTGGACCC - 3’
and 5’- TACTTGGCATAGCCCTCGTT - 3’
IDH2: 5’- CAGCACTGACTGTCCCCAG - 3’
and 5’- CACCGTCCATCTCCACTACC - 3’
OGDH: 5’- TGATGATGCTCCGGTAACTG - 3’
and 5’- AAGTGGTGGTGGGTAAGTGG - 3’
PCK1: 5’- CTGGATGAAGTTTGATGCCC - 3’
and 5’- TGTCTTCACTGAGGTGCCAG - 3’
PCK2: 5’- GTACTGGGAAGGCATTGACC - 3’
and 5’- AGTTTGGATGTGCACAGGGT - 3’
PDK2: 5’- ACGTCATTCACTTTCCTCCG - 3’
and 5’- TGGACATACCAGCTCTGCAC - 3’
PDK4: 5’- AGTGAACACTCCTTCGGTGC - 3’
and 5’- TGACAGGGCTTTCTGGTCTT - 3’
RBKS: 5’- GTAGTGGTGGGTTCCTGCAT - 3’
and 5’- CCTTTTCCTCCAAAGCCAA - 3’
UGP2: 5’- CAAGAAAAGGGACCGTCTGT - 3’
and 5’- GTTATCAGGCAAGCCTCTGG - 3’
cDNA was synthesized with 1 μg RNA using Prime-
Script™ RT reagent Kit with gDNA Eraser (Perfect Real
Time, Takara, Dalian, China)and mixed with SYBR® Pre-
mix Ex Taq™ II (Tli RNaseH Plus, Takara, Dalian, China)according to the manufacturer’s instructions. The quan-
titative expressions of genes, again, were calculated from
the CT value using the 2−ΔΔCT method. Those genes
with expressions less than 0.75-fold were selected fur-
ther for pathway and biological process analysis by using
WEB-based GEne SeT AnaLysis Toolkit (WebGestalt,
http://www.webgestalt.org/). Target genes were those ex-
pression significantly differed between the oil tea group
and db/db control group (p < 0.05) and were analyzed
the correlation with FBG further.
Selection of the human subjects
Eighty-six T2D patients and 286 healthy subjects were
recruited from the nutrition survey conducted in the mi-
nority areas in Gongcheng Yao Autonomous County and
Binyang County, Guangxi, China from 2014 to 2015. All
subjects were conducted with FBG or OGTT test. T2D
patients were selected based on the 1999 World Health
Organization diagnostic criteria [20]: FBG ≥7.0mmol/L or
OGTT≥11.1mmol/L or had self-reported diagnosed T2D.
Controls were the healthy subjects with normal glucose
level: FBG < 6.1mmol/L and OGTT < 7.8mmol/L without
T2D history. A standard questionnaire was administered by
trained staff to obtain information on demographic
characteristics, personal and family medical history, etc. This
study was approved by the Ethics Committee of Guangxi
Center for Disease Prevention and Control (No.
GXIRB2016–0014). All subjects provided informed consent.
Biochemical measurements and genotyping
Overnight fasting blood samples were obtained from
cases and controls for biochemical measurement and
genotyping. Participants without diagnosed diabetes
were given a standard 75-g OGTT with plasma glucose
measurement. Plasma glucose of FBG and OGTT were
measured using the hexokinase enzymatic method, and
serum triglyceride HDL-cholesterol and LDL-cholesterol
were assessed using commercially available reagents
(Shanghai Kehua Bio-engineering Co., Ltd., China) on an
automatic analyzer (Hitachi 7080; Hitachi, Tokyo, Japan).
DNA was isolated using the Thermo DNA Blood Kit
(ThermoFisher Scientific (China) Co., Ltd., Guangzhou,
China). Three polymorphisms (rs707555, rs2071023 and
rs2070755) in PCK1 were selected based on previous re-
search showing them to be significantly associated with
T2D [15–17]. SNPs genotyping used the MassARRAY
Genotyping System (Sequenom, BGI Tech., Wuhan,
China). The primers were designed using MassARRAY
Assay Design 3.0 software. The call rate of the genotyp-
ing SNPs achieved 99% or higher.
Statistical analyses
Data were expressed as means ± SD. Comparisons be-
tween two groups were performed with two-tailed t-test
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involved more than two groups were assessed by
one-way ANOVA followed by Newman–Keuls post-hoc
tests. The area under the curve (AUC) of OGTT was
calculated by the trapezoid rule [21]. Hardy-Weinberg
equilibrium (HWE) was analyzed by using the PLINK
[22] software. Logistic regression was used to examine
the association between the SNPs and T2D in the
case-control analysis. P-values less than 0.05 were
considered statistically significant. STATA version 12.0
(StataCorp LP, USA) was used for statistical analysis.
Results
Oil tea decreases fasting and postprandial glucose
During the 8-week experiment, lower FBG levels were
observed in both oil tea and MET treatment group, and
a significant decrease was observed from weeks 5 to 8 in
comparison with db/db control group (p < 0.05). At the
end of the experiment, the FBG level of the oil tea group
was significantly decreased to 15.68 ± 3.98 mmol/L, com-
pared with the db/db control group of 25.38 ± 8.24
mmol/L (p < 0.01). (Fig. 1a).
In the OGTT test, lower glucose levels were observed
in both the oil tea and MET treatment groups at weeks
4 and 8, compared to the control group. In particular,
significantly lower glucose levels were observed between
60min and 90min in the two groups, as well as at 120
min in the MET group (p < 0.05). However, no signifi-
cant differences were observed between oil tea groupFig. 1 Effect of oil tea on blood glucose in db/db mice. a Changes of fasti
of the oral glucose tolerance test (OGTT) at week 4. c The glucose levels of
fasting blood glucose; MET, metformin; AUC, area under the curve; control
presented as means ± SD. Differences were assessed by one-way ANOVA f
the control group (*p < 0.05, **p < 0.01)and control group at 120min, either at week 4 (p = 0.13)
or week 8 (p = 0.30). (Fig. 1b and c). As for AUC, signifi-
cantly lower levels were observed in both the oil tea and
MET treatment groups at weeks 4 and 8 (p < 0.05, Fig. 1d).
Oil tea lowers biochemical profiles
As shown in Fig. 2a-e, significantly lower TC levels
(p < 0.01) and a near-significantly lower TG level (p =
0.06) were observed in the oil tea treatment group com-
pared with the control group. Meanwhile, lower levels
of LDL (204.28 ± 90.14 vs 263.69 ± 110.40 mmol/L),
HDL (75.71 ± 18.16 vs 79.01 ± 17.49 mmol/L) and
insulin (3.66 ± 3.68 vs 4.17 ± 4.86 mmol/L) were
observed in the oil tea treatment group, although
these differences did not reach significance (p > 0.05).
However, no significant difference was observed
between the MET and control groups on any lipid
profile (p > 0.05).
No change on food intake and body weight gain with oil
tea treatment
When the mice were treated with oil tea, overall there
were no significant changes along the experiment except
significantly lower food intake were observed at weeks 3
(5.21 ± 0.69 vs 6.87 ± 1.00 g, p < 0.01) and 5 (4.59 ± 0.83
vs 5.31 ± 1.57 g, p < 0.05). When the mice were treated
with MET, the food intake was significantly lower at the
first week (2.76 ± 2.02 vs 5.32 ± 1.32 g, p < 0.05), while no
significantly difference was observed at later time pointsng blood glucose during the 8-week experiment. b The glucose levels
OGTT at week 8. d The AUC levels of OGTT at weeks 4 and 8. FBG,
group (n = 7); MET group (n = 10); oil tea group (n = 10). Values are
ollowed by Newman–Keuls post-hoc tests. *Significantly different from
Fig. 2 Effect on serum lipid in db/db mice treated with oil tea after 8 weeks. a Effect on TC treated with oil tea. b Effect on TG treated with oil
tea. c Effect on LDL treated with oil tea. d Effect on HDL treated with oil tea. e Effect on insulin treated with oil tea. TC, total cholesterol; TG,
triglycerides; LDL, low-density lipoprotein; HDL, high-density lipoprotein; MET, metformin; control group (n = 7); MET group (n = 10); oil tea group
(n = 10). Values are presented as means ± SD. Differences were assessed by one-way ANOVA followed by Newman–Keuls post-hoc tests.
*Significantly different from the control group (*p < 0.05, **p < 0.01)
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the experiment in all three groups. No significant
differences in weight gain were observed between the
oil tea and control groups, but a significantly greater
increase was observed in the MET group at weeks 7
and 8 (p < 0.05) (Fig. 3).
Oil tea decreases the expression of those genes involved
in glucose metabolism pathway
Ten genes involved in the glucose metabolism were
detected with different expressions between the oil tea
treatment mice and control mice. Out of the 10 genes
assessed, 9 genes’ fold change was less than 0.75-fold,
and the expression of UGP2 (fold change = 0.76) wassignificantly different between oil tea and control groups
(p = 0.02) (Fig. 4). When the 10 candidate genes were
validated by qPCR with the specific primers, we found
that all the genes’ expressions were down-regulated,
which were consistent with the RT2 profiler PCR array
results, and the consistent results were observed on the
housekeeping genes as well (data not shown). Further-
more, expression of five genes (PCK1, PCK2, ALDOA,
FBP2 and PDK4) differed less than 0.75-fold when oil
tea treatment group compared with control group
(Fig. 4). These five genes were further analyzed with
WebGestalt into pathway and functional annotation.
In particular, the expression of PCK1 was significantly
down-regulated after oil tea treatment compared to
controls (0.23 ± 0.13 vs. 0.40 ± 0.24, p < 0.05, Fig. 5a).
Fig. 3 Weekly body weight of mice. MET, metformin; control group (n = 7); MET group (n = 10); oil tea group (n = 10). Values are presented as
means ± SD. Differences were assessed by one-way ANOVA followed by Newman–Keuls post-hoc tests. *Significantly different from the control
group (*p < 0.05, **p < 0.01)
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We next examined the association between PCK1 ex-
pression and FBG levels. We found that increased PCK1
expression was significantly correlated with increasing
fasting glucose (R2 = 0.234, P < 0.05, Fig. 5b). However,
the expression of other four candidate genes (ALDOA,
FBP2, PCK2 and PDK4) were not significantly associated
with fasting glucose level (data not shown).Fig. 4 Fold changes of the candidate genes expressions between oil tea a
qPCR. Differences were assessed by t-test or Wilcoxon rank-sum test, as ap
expression (*p < 0.05)Prediction and functional annotation by WebGestalt on PCK1
By using WebGestalt, the functional annotation results
showed that PCK1 in company with other four
candidate genes (PCK2, ALDOA, FBP2, and PDK4) were
mainly involved in glycolysis/gluconeogenesis, AMPK
and insulin signaling pathway (Fig. 6a). Analysis on
function, biological process showed PCK1 and the other
four candidate genes to be involved in ten types ofnd control groups by using RT2 profiler PCR array and validated with
propriate. *Significantly different from the control group on gene
Fig. 5 PCK1 expression responded to oil tea treatment. a Decreased hepatic PCK1 expression in oil tea treatment group. b Correlation between
PCK1 expression and fasting glucose levels. FBG, fasting blood glucose; control group (n = 7); oil tea group (n = 10). Values are presented as
means ± SEM. Differences were assessed by t-test. Correlation analysis was performed with Pearson pairwise test
Hu et al. Nutrition & Metabolism           (2019) 16:12 Page 7 of 12biological process, including six types of metabolic
process (hexose, monosaccharide, glucose, carbohy-
drate and pyruvate metabolic process), gluconeogene-
sis and three types of biosynthetic process. (Fig. 6b,
Additional file 1: Table S1).General characteristics of the human subjects in the
case-control analysis
A total of 372 subjects were recruited in the minority
areas of Guangxi, China, including 86 T2D cases and
285 healthy controls. The clinical characteristics and
biochemical indexes between T2D patients and controls
are shown in Table 1. Significant differences were
observed in age, sex, BMI, FBG, LDL, TC, TG and
anemia between the two groups, all higher among the
cases than controls.The association between the PCK1 SNPs and type 2 diabetes
The three tested SNPs were in Hardy-Weinberg equilib-
rium with p > 0.05. As shown in the Table 2, two SNPs
(rs707555 and rs2071023) were significantly associated
with T2D, persisting after adjustment for age, sex, BMI,
family history of diabetes, TC and TG (Ptrend = 0.002 and
Ptrend = 0.02, respectively). A clear dose response was
observed with the two SNPs as well, such that compared
to those non-carrying G allele of rs707555, the subjects
carrying one or two of G alleles decreased 62% (OR =
0.38, p = 0.002) and 82% (OR = 0.18, p = 0.08) risk of
T2D, respectively. As for rs2071023, those subjects
carrying one or two of G alleles increased 1.94 times
(p = 0.03) and 2.39 times (p = 0.07) risk of T2D, re-
spectively. Meanwhile, a significant negative correl-
ation between rs707555 and FBG level was observed
after adjustment for age, sex, BMI, family history of
Fig. 6 Pathway and functional ranking summary of PCK1. a Pathway ranking summary of PCK1. b Functional and biological process ranking
summary of PCK1. Pathways were annotated according to KEGG, and functional and biological process were annotated by using WebGestalt.
Score = −log (false discovery rate, FDR)
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nificant positive correlation between rs2071023 and
TG level after adjustment for age, sex, BMI and TC
(Ptrend = 0.027). However, no significance was observed
between the correlation of 2,071,023 and FBG,
rs707555 and TG. No significant associations wereTable 1 The main phenotypic characteristics of the study participan
Controls (n = 285)
Sex (male/female) 89/196
Age (years) 53.56 ± 16.33
BMI (Kg/m2) 22.57 ± 3.60
TG (mmol/L) 1.45 ± 0.84
TC (mmol/L) 4.69 ± 1.10
FBG (mmol/L) 4.86 ± 0.64
HDL-cholesterol (mmol/L) 1.77 ± 0.46
LDL-cholesterol (mmol/L) 2.27 ± 0.80
Anemia (n, %) 36 (12.9%)
Family history of diabetes (n, %) 17 (5.96%)
BMI body mass index, TG triglyceride, TC total cholesterol, FBG fasting blood glucosobserved between rs2070755 and T2D, FBG or TG
(Additional file 1: Table S2).
Discussion
In the present study, we have shown that oil tea treatment
can impact upon glucose homeostasis in type 2 diabeticts
T2D Patients (n = 86) p-value
45/41 < 0.001
62.62 ± 11.90 < 0.001
23.96 ± 3.24 0.003
2.03 ± 1.67 < 0.001
5.26 ± 1.02 < 0.001
8.57 ± 4.02 < 0.001
1.72 ± 0.57 0.4025
2.62 ± 0.80 0.0004
35 (40.7%) < 0.001
3 (3.49%) 0.373
e, HDL high density lipoprotein, LDL low density lipoprotein
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total cholesterol, and improved glucose tolerance. We also
identified suppression of hepatic PCK1 in oil tea-treated
db/db mice, and PCK1 expression significantly correlated
with the level of fasting blood glucose. PCK1 was mainly
involved in the glycolysis/gluconeogenesis pathway, and
two SNPs (rs707555 and rs2071023) in PCK1 were signifi-
cantly associated with T2D in the minority population in
Guangxi, China.
Oil tea is a type of traditional tea beverage traditionally
used in the minority areas in Guangxi Province, China
for prevention and treatment of multiple ailments [2].
The main ingredients of oil tea - green tea and ginger,
are well-known Chinese Materia Medica [23], having
been traditionally used in traditional Chinese medicine
and Southeast Asian system medicine [4, 24]. Recent
evidence has shown green tea and ginger individually
exert antidiabetic effects, including in animal experi-
ments [5, 25–27], cohort studies [28, 29], and random-
ized controlled trials [3, 30]. As a complex mixture of
green tea, ginger and oil, we previously showed that oil
tea improved hyperglycemia, glucose intolerance and
hyperlipidemia in db/db mice [1]. In the present study,
the similar beneficial effects on anti-diabetes of oil tea
were observed as well.
To explore the underlying mechanisms of oil tea
induced antidiabetic effects, the expression of 84 genes
involved in glucose metabolism were examined. Five
candidate genes were found with expression changed
following oil tea treatment, and they were mainly
involved in the glycolysis/gluconeogenesis pathway and
participated in different types of metabolism process in-
cluding glucose metabolic process and gluconeogenesis.
It is well established that the rate of gluconeogenesis is
modulated by several enzymes, including PCK,
fructose-1, 6-biphosphatase, and glucose-6-phosphatase
[31–33], in which PCK1 catalyzes the first committed
step [34]. In this study, we found that PCK1 expression
was significantly down-regulated after oil tea treatment,
and this down-regulation was positive correlated with
fasting glucose level in db/db mice. This indicated the
observed decreased glucose level may be due to a lower
gluconeogenesis rate due to decreased expression of
PCK1. PCK1 is mainly involved in glycolysis/gluconeo-
genesis pathways, as well as glucose related-biological
process which are involved in glucose homeostasis and
type 2 diabetes [35, 36]. These suggest PCK1 may act via
glycolysis/gluconeogenesis pathways and thus affect
diabetes status during oil tea treatment. Notably, as the
first-line medication for treating T2D, MET was de-
signed as the positive control in the animal experiment.
It is interesting to find that oil tea showed a cumulative
effect on glucose control over days/weeks, while MET
affected glucose level much earlier. This indicate METknocks the gluconeogenesis pathway on the head, while
oil tea works in a slower route, for reducing expression
of PCK1 and as it accumulates over days/weeks, glucose
levels reduce.
Supporting these results, two SNPs (the missense
rs707555 and the promoter rs2071023) in PCK1 were
found to be associated with T2D in minority population
in Guangxi, which has a high consumption of oil tea.
Previously, research in the Eastern Chinese population
showed both of these SNPs were associated with the risk
of T2D [15]. Although a different allelic frequency of
rs707555 was observed in the minority population of
Guangxi, the association between the two SNPs and
T2D were consistent with that of in the Eastern Chinese
population. Furthermore, we also found that those sub-
jects carrying CG genotype of rs707555 had significantly
lower FBG, and people carrying GG genotype of
rs2071023 were significantly correlated with higher TG.
These findings further supported the association be-
tween the two SNPs and T2D since FBG and TG are the
key biochemical markers of T2D. Taken together, these
results suggest that PCK1 is a genetic marker of T2D in
the Chinese minority population, and thus, interventions
which decrease PCK1 gene expression, such as oil tea
consumption, may be effective for T2D prevention or
treatment. However, such beneficial effects of oil tea
requires investigation in randomized controlled trials.
Conclusions
Overall, we found that oil tea improved fasting and
postprandial glucose and total cholesterol. We have
identified a potential molecular mechanism underlying
oil tea induced-antidiabetic effects through which
expression of PCK1 was reduced. Our findings suggest
PCK1 plays a key role in the beneficial effects of oil tea,
and PCK1 may be a potential genetic marker for the
treatment of type 2 diabetes. Randomized controlled
trials to substantiate the clinical efficacy of oil tea in
T2D are required.
Additional file
Additional file 1: Table S1. The enriched terms of differential
expression genes by using WebGestalt. Table S2. The association
between the rs20707555 in PCK1 and type 2 diabetes, FBG and TG.
(DOC 68 kb)
Abbreviations
AUC: area under the curve; BW: body weight; CT: cycle threshold;
FBG: fasting blood glucose; FDR: false discovery rate; HWE: Hardy-Weinberg
equilibrium; KEGG: Kyoto Encyclopedia of Genes and Genomes;
MET: metformin; OGTT: oral glucose tolerance test;
PCK1: Phosphoenolpyruvate carboxykinase 1; PCR: polymerase chain reaction;
qPCR: quantitative PCR; RT: real-time; SNP: single nucleotide polymorphism;
T2D: type 2 diabetes; TC: total cholesterol; TG: triglycerides; WebGestalt: WEB-
based GEne SeT AnaLysis Toolkit
Hu et al. Nutrition & Metabolism           (2019) 16:12 Page 11 of 12Acknowledgements
Not applicable.
Funding
This work was supported by the National Natural Science Foundation of
China (No.81660540), Natural Science Foundation of Guangxi Province
(Grant No. 2015GXNSFCA139010) and the Hundred Talents Program of
Guangxi universities (No. GuiJiaoRen [2016] 56).
Availability of data and materials
The datasets used during the present study are available from the
corresponding author upon reasonable request.
Authors’ contributions
Conceptualization, HZ and RL; Data curation, HC; Formal analysis, QH and YZ;
Investigation, HC, QH, XH, WH and HY; Supervision, RL; Writing – original
draft, RL; Writing – review & editing, SS. All authors read and approved the
final manuscript.
Ethics approval
The animal experimental protocols used in this study were approved by the
Animal Ethics Committee of Guangxi Center for Disease Prevention and
Control (No. 20160003). The protocol of population study was approved by
the Ethics Committee of Guangxi Center for Disease Prevention and Control
(No.GXIRB2016–0014), all the participants signed informed consent.
Consent for publication
Not applicable.
Competing interests
The authors declare that they have no competing interests.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in
published maps and institutional affiliations.
Author details
1Center for Genomic and Personalized Medicine, Guangxi Medical University,
22 Shuangyong Road, Nanning 530021, Guangxi, China. 2Guangxi Center for
Disease Prevention and Control, Nanning, China. 3General Practice School,
Guangxi Medical University, Nanning, China. 4Melbourne School of
Population & Global Health, University of Melbourne, Carlton, Australia.
5Menzies Institute for Medical Research, University of Tasmania, Hobart,
Australia. 6Public Health School, Guangxi Medical University, 22 Shuangyong
Road, Nanning 530021, Guangxi, China.
Received: 9 November 2018 Accepted: 24 January 2019
References
1. Lin R, He X, Chen H, He Q, Yao Z, Li Y, Yang H, Simpson S Jr. Oil tea
improves glucose and lipid levels and alters gut microbiota in type 2
diabetic mice. Nutr Res. 2018;57:67–77.
2. Hong X. Yao tea and disease preventiona and ailment treatment. J Med
Pharm Chin Minorities. 2015;21:75–6.
3. Liu K, Zhou R, Wang B, Chen K, Shi LY, Zhu JD, Mi MT. Effect of green tea
on glucose control and insulin sensitivity: a meta-analysis of 17 randomized
controlled trials. Am J Clin Nutr. 2013;98:340–8.
4. Bode AM, Dong Z. The amazing and mighty ginger. In herbal medicine:
biomolecular and clinical aspects. 2nd edition. Edited by Benzie IFF,
Wachtel-Galor S. Boca Raton: CRC Press/Taylor & Francis; 2011.
5. Akash MS, Rehman K, Tariq M, Chen S. Zingiber officinale and type 2
diabetes mellitus: evidence from experimental studies. Crit Rev Eukaryot
Gene Expr. 2015;25:91–112.
6. Hanson RW, Reshef L. Regulation of phosphoenolpyruvate carboxykinase
(GTP) gene expression. Annu Rev Biochem. 1997;66:581–611.
7. Clouthier DE, Comerford SA, Hammer RE. Hepatic fibrosis,
glomerulosclerosis, and a lipodystrophy-like syndrome in PEPCK-TGF-beta1
transgenic mice. J Clin Invest. 1997;100:2697–713.
8. Sun Y, Liu S, Ferguson S, Wang L, Klepcyk P, Yun JS, Friedman JE.
Phosphoenolpyruvate carboxykinase overexpression selectively attenuatesinsulin signaling and hepatic insulin sensitivity in transgenic mice.
J Biol Chem. 2002;277:23301–7.
9. Valera A, Pujol A, Pelegrin M, Bosch F. Transgenic mice overexpressing
phosphoenolpyruvate carboxykinase develop non-insulin-dependent
diabetes mellitus. Proc Natl Acad Sci U S A. 1994;91:9151–4.
10. Gomez-Valades AG, Mendez-Lucas A, Vidal-Alabro A, Blasco FX, Chillon M,
Bartrons R, Bermudez J, Perales JC. Pck1 gene silencing in the liver improves
glycemia control, insulin sensitivity, and dyslipidemia in db/db mice.
Diabetes. 2008;57:2199–210.
11. Runtuwene J, Cheng KC, Asakawa A, Amitani H, Amitani M, Morinaga A,
Takimoto Y, Kairupan BH, Inui A. Rosmarinic acid ameliorates hyperglycemia
and insulin sensitivity in diabetic rats, potentially by modulating the
expression of PEPCK and GLUT4. Drug Des Devel Ther. 2016;10:2193–202.
12. Li Y, Liu Y, Chen G. Vitamin a status affects the plasma parameters and
regulation of hepatic genes in streptozotocin-induced diabetic rats.
Biochimie. 2017;137:1–11.
13. Oda H, Okuda Y, Yoshida Y, Kimura N, Kakinuma A. Phenobarbital reduces
blood glucose and gluconeogenesis through down-regulation of
phosphoenolpyruvate carboxykinase (GTP) gene expression in rats. Biochem
Biophys Res Commun. 2015;466:306–11.
14. Beale EG, Harvey BJ, Forest C. PCK1 and PCK2 as candidate diabetes and
obesity genes. Cell Biochem Biophys. 2007;48:89–95.
15. Dong Y, Zhang H, Wang X, Feng Q, Chen X, Su Q. A Leu184Val polymorphism
in PCK1 gene is associated with type 2 diabetes in eastern Chinese population
with BMI<23 kg/m2. Diabetes Res Clin Pract. 2009;83:227–32.
16. Rees SD, Britten AC, Bellary S, O'Hare JP, Kumar S, Barnett AH, Kelly MA. The
promoter polymorphism -232C/G of the PCK1 gene is associated with type
2 diabetes in a UK-resident south Asian population. BMC Med Genet.
2009;10:83.
17. Willer CJ, Bonnycastle LL, Conneely KN, Duren WL, Jackson AU, Scott LJ,
Narisu N, Chines PS, Skol A, Stringham HM, et al. Screening of 134 single
nucleotide polymorphisms (SNPs) previously associated with type 2
diabetes replicates association with 12 SNPs in nine genes. Diabetes.
2007;56:256–64.
18. Hou X, Hao E, Fan L, Du Z, Xie H, Qin J, Xie J, Deng J. Study on the scientific
connotation and industrial development of oil tea in Gongcheng Yao
Autonomous County, Guangxi. J Med Pharm Chin Minorities. 2017;7:1–4.
19. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using
real-time quantitative PCR and the 2(−Delta Delta C(T)) method. Methods.
2001;25:402–8.
20. Department of Noncommunicable Disease Surveillance. Definition,
diagnosis and classification of diabetes mellitus and its complications:
report of a WHO consultation. Part 1. Diagnosis and classification of
diabetes mellitus. Geneva: World Health Organization; 1999.
21. Liu Z, Yang Z, Jiang L, Gao H. The effect of Youfuquan water on type 2
diabetic rats. Med J Qilu. 2015;30:677–80.
22. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, Bender D, Maller J,
Sklar P, de Bakker PI, Daly MJ, Sham PC. PLINK: a tool set for whole-genome
association and population-based linkage analyses. Am J Hum Genet. 2007;
81:559–75.
23. Li S. Compendium of Materia Medica. Beijing: China Press of Traditional
Chinese Medicine; 2013.
24. Serafini M, Del Rio D, Yao DN, Bettuzzi S, Peluso I. Health Benefits of Tea. In:
IFF B, Wachtel-Galor S, editors. Herbal Medicine: Biomolecular and Clinical
Aspects. 2nd edition. Boca Raton (FL): CRC Press/Taylor & Francis; 2011.
25. Ortsater H, Grankvist N, Wolfram S, Kuehn N, Sjoholm A. Diet
supplementation with green tea extract epigallocatechin gallate prevents
progression to glucose intolerance in db/db mice. Nutr Metab (Lond).
2012;9:11.
26. Wein S, Schrader E, Rimbach G, Wolffram S. Oral green tea catechins
transiently lower plasma glucose concentrations in female db/db mice.
J Med Food. 2013;16:312–7.
27. Bae KC, Park JH, Na AY, Kim SJ, Ahn S, Kim SP, Oh BC, Cho HC, Kim YW,
Song DK. Effect of green tea extract/poly-gamma-glutamic acid complex in
obese type 2 diabetic mice. Diabetes Metab J. 2013;37:196–206.
28. Yang WS, Wang WY, Fan WY, Deng Q, Wang X. Tea consumption and risk
of type 2 diabetes: a dose-response meta-analysis of cohort studies.
Br J Nutr. 2014;111:1329–39.
29. Jing Y, Han G, Hu Y, Bi Y, Li L, Zhu D. Tea consumption and risk of
type 2 diabetes: a meta-analysis of cohort studies. J Gen Intern Med.
2009;24:557–62.
Hu et al. Nutrition & Metabolism           (2019) 16:12 Page 12 of 1230. Mozaffari-Khosravi H, Talaei B, Jalali BA, Najarzadeh A, Mozayan MR. The
effect of ginger powder supplementation on insulin resistance and
glycemic indices in patients with type 2 diabetes: a randomized, double-
blind, placebo-controlled trial. Complement Ther Med. 2014;22:9–16.
31. Surwit RS, Kuhn CM, Cochrane C, McCubbin JA, Feinglos MN. Diet-induced
type II diabetes in C57BL/6J mice. Diabetes. 1988;37:1163–7.
32. Vidal-Puig A, O'Rahilly S. Metabolism. Controlling the glucose factory.
Nature. 2001;413:125–6.
33. Shao J, Qiao L, Janssen RC, Pagliassotti M, Friedman JE. Chronic
hyperglycemia enhances PEPCK gene expression and hepatocellular
glucose production via elevated liver activating protein/liver inhibitory
protein ratio. Diabetes. 2005;54:976–84.
34. Quinn PG, Yeagley D. Insulin regulation of PEPCK gene expression: a model
for rapid and reversible modulation. Curr Drug Targets Immune Endocr
Metabol Disord. 2005;5:423–37.
35. Oh KJ, Han HS, Kim MJ, Koo SH. Transcriptional regulators of hepatic
gluconeogenesis. Arch Pharm Res. 2013;36:189–200.
36. Desjardins EM, Steinberg GR. Emerging role of AMPK in Brown and Beige
adipose tissue (BAT): implications for obesity, insulin resistance, and type 2
diabetes. Curr Diab Rep. 2018;18:80.
